鬆齡護老集團(01989.HK):公眾持股量恢復,下週一復牌
格隆匯 10 月 9日丨鬆齡護老集團(01989.HK)公佈,公司獲要約方告知,於要約截止後及直至公告日期,要約方已完成向與公司或其任何核心關連人士概無關連且並非與要約方一致行動人士的獨立第三方出售合共2.04億股現有股份,相當於公司於公告日期已發行股本總額約22.54%。
緊隨出售事項完成後及於公告日期,2.26億股股份(相當於公司已發行股本總額約25.06%)由公眾人士持有。因此,根據上市規則第8.08(1)(a)條,公司的公眾持股量已恢復至不少於公司已發行股本總額的25%。
公司已向聯交所申請股份自2020年10月12日(星期一)上午九時正起於聯交所恢復買賣。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.